• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pulmonary Embolism as a Cause of Death in Lung Transplant Recipients: Data From a Nationwide Registry.肺栓塞作为肺移植受者的死亡原因：来自全国性登记处的数据。
Pulm Circ. 2025 Mar 11;15(1):e70056. doi: 10.1002/pul2.70056. eCollection 2025 Jan.
2
Long-term risk of pulmonary embolism in solid-organ transplant recipients.实体器官移植受者发生肺栓塞的长期风险。
Exp Clin Transplant. 2015 Apr;13 Suppl 1:223-7.
3
[A single-center experience of venous thromboembolism after adult lung transplantation].[成人肺移植术后静脉血栓栓塞的单中心经验]
Zhonghua Jie He He Hu Xi Za Zhi. 2019 Sep 12;42(9):694-699. doi: 10.3760/cma.j.issn.1001-0939.2019.09.008.
4
The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation.多器官供体中肺栓塞对后续肺、肾和心脏移植的影响。
J Heart Lung Transplant. 2008 Jan;27(1):78-85. doi: 10.1016/j.healun.2007.10.001.
5
Pulmonary embolism on postmortem examination: an under-recognized complication in lung-transplant recipients?尸检发现的肺栓塞：肺移植受者中一种未被充分认识的并发症？
Transplantation. 2004 Mar 15;77(5):692-8. doi: 10.1097/01.tp.0000114308.94880.2a.
6
Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.实体器官移植受者的静脉血栓栓塞症：RIETE 注册研究的结果。
Thromb Res. 2021 May;201:131-138. doi: 10.1016/j.thromres.2021.02.022. Epub 2021 Feb 25.
7
Acute pulmonary embolism treatment in lung transplant recipients: mechanical thrombectomy and catheter directed thrombolysis.肺移植受者急性肺栓塞的治疗：机械血栓切除术和导管定向溶栓术。
CVIR Endovasc. 2025 Mar 11;8(1):19. doi: 10.1186/s42155-024-00512-z.
8
Pulmonary embolism and pulmonary infarction after lung transplantation.肺移植后肺栓塞和肺梗死。
Clin Appl Thromb Hemost. 2011 Aug;17(4):421-4. doi: 10.1177/1076029610371474. Epub 2010 Jun 13.
9
Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).美国的肠道和多脏器移植：20年国家登记数据报告（1990 - 2009年）
Clin Transpl. 2009:83-101.
10
Rescue kidneys in lung transplantation: A retrospective analysis of recipients who might have benefitted from a kidney safety net.肺移植中的挽救性肾脏：对可能受益于肾脏安全保障的受者的回顾性分析。
J Heart Lung Transplant. 2025 Aug;44(8):1215-1222. doi: 10.1016/j.healun.2025.03.025. Epub 2025 Apr 3.

本文引用的文献

1
Cardiovascular Disease and Thrombosis in HIV Infection.HIV 感染相关心血管疾病与血栓
Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):175-191. doi: 10.1161/ATVBAHA.122.318232. Epub 2022 Dec 1.
2
Clinical Outcomes of Lung Transplants From Donors With Unexpected Pulmonary Embolism.从患有意外肺栓塞供体中获得的肺移植的临床结果。
Ann Thorac Surg. 2021 Aug;112(2):387-394. doi: 10.1016/j.athoracsur.2020.08.040. Epub 2020 Oct 22.
3
Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome-wide association study.供体遗传变异作为肝移植后血栓形成的危险因素：一项全基因组关联研究。
Am J Transplant. 2021 Sep;21(9):3133-3147. doi: 10.1111/ajt.16490. Epub 2021 Feb 11.
4
ABO incompatibility as a possible risk factor for hepatic artery thrombosis in living donor liver transplantation.ABO血型不相容作为活体肝移植中肝动脉血栓形成的一个潜在风险因素。
Ann Transl Med. 2020 May;8(10):616. doi: 10.21037/atm.2020.03.97.
5
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment.癌症相关血栓形成：机制、危险因素及治疗概述
Cancers (Basel). 2018 Oct 11;10(10):380. doi: 10.3390/cancers10100380.
6
Prophylaxis with enoxaparin for prevention of venous thromboembolism after lung transplantation: a retrospective study.依诺肝素预防肺移植术后静脉血栓栓塞症的预防性治疗：一项回顾性研究。
Transpl Int. 2017 Dec;30(12):1266-1274. doi: 10.1111/tri.13021. Epub 2017 Sep 7.
7
Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients.评估依诺肝素剂量作为肺移植受者出血危险因素的情况。
Ann Pharmacother. 2016 Oct;50(10):824-31. doi: 10.1177/1060028016656434. Epub 2016 Jun 29.
8
Treatment with everolimus is associated with a procoagulant state.依维莫司治疗与促凝状态相关。
Thromb Res. 2013 Aug;132(2):307-11. doi: 10.1016/j.thromres.2013.07.004. Epub 2013 Jul 29.
9
Sirolimus use and incidence of venous thromboembolism in cardiac transplant recipients.西罗莫司在心脏移植受者中的应用与静脉血栓栓塞症的发生。
Clin Transplant. 2012 Nov-Dec;26(6):953-9. doi: 10.1111/j.1399-0012.2012.01677.x. Epub 2012 Jul 9.
10
Acute pulmonary embolism after pneumonectomy.肺切除术后急性肺栓塞。
J Thorac Dis. 2012 Feb;4(1):76-82. doi: 10.3978/j.issn.2072-1439.2011.10.02.

肺栓塞作为肺移植受者的死亡原因：来自全国性登记处的数据。

Pulmonary Embolism as a Cause of Death in Lung Transplant Recipients: Data From a Nationwide Registry.

作者信息

Kim Hye Sung, Gupta Rohit, Rali Parth

机构信息

Department of Medicine Temple University Hospital Philadelphia Pennsylvania USA.

Northwestern University Feinberg School of Medicine Chicago Illinois USA.

出版信息

Pulm Circ. 2025 Mar 11;15(1):e70056. doi: 10.1002/pul2.70056. eCollection 2025 Jan.

DOI:10.1002/pul2.70056
PMID:40071063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11894438/
Abstract

Pulmonary embolism (PE) is a leading cause of mortality in lung transplant recipients, with early cases associated with particularly poor outcomes. Identified risk factors include elevated BMI, renal dysfunction, ABO mismatch, donor malignancy, and specific immunosuppressive agents. Tailored risk assessments and targeted interventions are essential to mitigating PE-related mortality.

摘要

肺栓塞（PE）是肺移植受者死亡的主要原因，早期病例的预后尤其差。已确定的风险因素包括体重指数升高、肾功能不全、ABO血型不匹配、供体恶性肿瘤以及特定的免疫抑制剂。定制的风险评估和有针对性的干预对于降低与PE相关的死亡率至关重要。